|
SSRI antidepressants do not pose major birth defect risk
June 28, 2007Certain antidepressants may have modest effects
Boston, MA -- Researchers from Boston University's Slone Epidemiology Center have found that certain selective serotonin reuptake inhibitors antidepressants do not appear to increase the risk for most kinds of birth defects. The findings, to be published in the June 28, issue of the New England Journal of Medicine, suggest that individual SSRIs may increase the risk for some specific defects, but these are rare and the absolute risks are small.
The risk of birth defects following antenatal exposure to SSRIs remains controversial. Early studies demonstrated that SSRIs didn't increase risks of birth defects when such defects were studied as a group. However, birth defects are not a single entity and individual defects have distinct causes. And, more recent studies have reported elevated risks for some birth defects.
Using data from the Slone Epidemiology Center's Birth Defects Study, an ongoing program of case-control surveillance of medication use in relation to birth defects, the researchers considered relationships between first trimester SSRI use and the risk of various birth defects among mothers of 9,849 infants with birth defects and 5,860 infants without defects.
The researchers analyzed defects previously linked to SSRI use and found overall SSRI use was not associated with significantly increased risks of craniosynostosis (where connections between skull bones close prematurely), omphalocele (intestines or other abdominal organs protrude from the naval) or heart defects overall.
Analysis of individual SSRIs and specific defects showed significant associations between setraline (e.g. Zoloft) and omphalocele and septal defects (defects in the walls that separate the chambers of the heart) and between the paroxetine (e.g. Paxil) and certain heart defects that interfere with blood flow to the lungs. This last association was also reported in another paper, from the CDC's National Birth Defects Prevention Study, in this week's NEJM. However, the BU researchers stress that even if a specific SSRI increased rates four-fold, as was observed for some of these associations, the risk of having an affected child would be less than one percent.
"Our analyses did not confirm previously reported associations between overall use of SSRIs and a number of birth defects," said lead author Carol Louik, ScD, an assistant professor at the Slone Epidemiology Center at Boston University. "Rather our study suggests that risks are limited to specific SSRIs in relation to specific birth defects. Still, it is important to keep in perspective that the baseline risks for these rare defects are small, so even if the modest increased risks we observed are correct, the chances of having a child with such a defect are quite small," she added.
Boston University
Using data from the Slone Epidemiology Center's Birth Defects Study, an ongoing program of case-control surveillance of medication use in relation to birth defects, the researchers considered relationships between first trimester SSRI use and the risk of various birth defects among mothers of 9,849 infants with birth defects and 5,860 infants without defects.
The researchers analyzed defects previously linked to SSRI use and found overall SSRI use was not associated with significantly increased risks of craniosynostosis (where connections between skull bones close prematurely), omphalocele (intestines or other abdominal organs protrude from the naval) or heart defects overall.
Analysis of individual SSRIs and specific defects showed significant associations between setraline (e.g. Zoloft) and omphalocele and septal defects (defects in the walls that separate the chambers of the heart) and between the paroxetine (e.g. Paxil) and certain heart defects that interfere with blood flow to the lungs. This last association was also reported in another paper, from the CDC's National Birth Defects Prevention Study, in this week's NEJM. However, the BU researchers stress that even if a specific SSRI increased rates four-fold, as was observed for some of these associations, the risk of having an affected child would be less than one percent.
"Our analyses did not confirm previously reported associations between overall use of SSRIs and a number of birth defects," said lead author Carol Louik, ScD, an assistant professor at the Slone Epidemiology Center at Boston University. "Rather our study suggests that risks are limited to specific SSRIs in relation to specific birth defects. Still, it is important to keep in perspective that the baseline risks for these rare defects are small, so even if the modest increased risks we observed are correct, the chances of having a child with such a defect are quite small," she added.
Boston University
Birth Defect News and Current Birth Defect Events RSSSexually transmitted disease, urinary tract infections may be bad combination for birth defect Chances of gastroschisis increase fourf
Women who reported having both a sexually transmitted disease (STD) and urinary tract infection (UTI) just before or during early pregnancy were four times more likely to have babies with gastroschisis-a severe birth defect in which infants are born with their intestines and other internal organs outside the abdomen, University of Utah researchers report in the online British Medical Journal.
Is tap water safe for expectant mothers?
Drinking water disinfected by chlorine while pregnant may increase the risk of having children with heart problems, cleft palate or major brain defects, according to a study published today in BioMed Central's open access journal Environmental Health.
Analysis of millions of US births shows association between birth defects and preterm birth
Babies born preterm were more than twice as likely to have major birth defects as full-term infants, according to a new analysis of nearly 7 million U.S. live births published online this week in the Springer journal Maternal and Child Health Journal.
Oregon researchers discover a mechanism leading to cleft palate
By creating a genetic mutation in zebrafish, University of Oregon scientists say they've discovered a previously unknown mechanism for cleft palate, a common birth defect in humans that has challenged medical professionals for centuries.
UT-Houston's Northrup and Colleagues Uncover Genetic Link to Spina Bifida
Researchers at The University of Texas Medical School at Houston have discovered an association between genes regulating glucose metabolism and spina bifida. The decade-long study looked at more than 1,500 DNA samples from parents and their children with that birth defect.
New findings solve human origins mystery
An extraordinary advance in human origins research reveals evidence of the emergence of the upright human body plan over 15 million years earlier than most experts have believed.
Adverse drug events reported to FDA appear to have increased markedly
The number of serious adverse drug events reported to the U.S. Food and Drug Administration (FDA) more than doubled between 1998 and 2005, as did deaths associated with adverse drug events.
New data reveal pregnancies exposed to accutane despite risk management program
Despite a mandatory program designed to prevent pregnant women from being exposed to the anti-acne medication Accutane and similar medications containing isotretinoin (a known teratogen or birth defect-causing agent), 122 pregnancies were exposed during the first year of the program, known as iPledge, a report revealed.
New genetic mutations found that may cause cleft lip/palate
University of Iowa researchers and collaborators have identified new genetic mutations that likely cause the common form of cleft lip and palate.
Cleft palate in fetal mice prevented by treating
Mice engineered to have cleft palates can be rescued in utero by injecting the mothers with a small molecule to correct the defect, say scientists at the Stanford University School of Medicine and Lucile Packard Children's Hospital.
More Birth Defect News Articles
 | Before We Are Born: Essentials of Embryology and Birth Defects (Before We Are Born: Essentials of Embryology & Birth Defects) by Keith L. Moore, T. V. N. Persaud |
 | Before We Are Born: Essentials of Embryology and Birth Defects With STUDENT CONSULT Online Access (Before We Are Born: Essentials of Embryology & Birth Defects) by Keith L. Moore, T. V. N. Persaud |
 | Lippy The Lion by Joanne Green |
 | Coping with Physical Loss and Disability: A Workbook (New Horizons in Therapy) by Rick Ritter |
 | The Encyclopedia of Genetic Disorders and Birth Defects (Facts on File Library of Health and Living) by James Wynbrandt, Mark D., M.D. Ludman |
 | Abnormal Skeletal Phenotypes: From Simple Signs to Complex Diagnoses by Alessandro Castriota-Scanderbeg, Bruno Dallapiccola |
 | Chemically Induced Birth Defects, Third Edition, (Chemically Induced Birth Defects) by James Schardein |
 | First, Do No Harm by Larry Karp |
| Birth Defects Encyclopaedia | |
 | Expect a Miracle: Unwavering Faith Through Fetal Surgery by Andrea Merkord |
| © 2008 BrightSurf.com |